miR‐155 has been shown to promote endothelial dysfunction by inhibiting endothelial nitric oxide synthase (eNOS) expression and decreasing endothelium‐dependent vasorelaxation (Sun et al., 2012). This evidence concerns the gene NOS3 and endothelial dysfunction.